Two-year experience with FK 506 in pediatric patients.
Tzakis
A G
AG
Transplant Institute, University of Pittsburgh, PA 15213.
Reyes
J
J
Todo
S
S
Nour
B
B
Shapiro
R
R
Jordan
M
M
McCauley
J
J
Armitage
J
J
Fung
J J
JJ
Starzl
T E
TE
D000293:Adolescent; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000009:adverse effects; D005500:Follow-Up Studies; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D007421:Intestine, Small / Q000637:transplantation; D016031:Liver Transplantation / Q000276:immunology*; D016040:Lung Transplantation / Q000276:immunology*; D008232:Lymphoproliferative Disorders / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use; D016019:Survival Analysis; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone; D016559:Tacrolimus